Dynavax Technologies reported $129.61M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Adma Biologics ADMA:US $ 42.41M 19.56M
Agenus AGEN:US $ 73.54M 45.82M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Amgen AMGN:US $ 6630M 518M
AstraZeneca AZN:LN 15567M 7931M
Astrazeneca AZN:US $ 15567M 7931M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
BioSpecifics Technologies BSTC:US 2.87M 14M
Bristol Myers Squibb BMY:US $ 11024M 42M
Chimerix CMRX:US $ 25.44M 6.64M
Dynavax Technologies DVAX:US $ 129.61M 50.55M
Gilead Sciences GILD:US $ 7361M 3296M
Glaxosmithkline GSK:US $ 3503M 1254M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Idera Pharmaceuticals IDRA:US $ 40.59M 3.95M
Minerva Neurosciences NERV:US $ 74.22M 5.92M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Novartis NOVN:VX SF 5117M 1316M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Tg Therapeutics TGTX:US $ 456.22M 15.3M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M